NO20072325L - Kombinasjonsterapi omfattende telmisartan og hydroklortiazid - Google Patents

Kombinasjonsterapi omfattende telmisartan og hydroklortiazid

Info

Publication number
NO20072325L
NO20072325L NO20072325A NO20072325A NO20072325L NO 20072325 L NO20072325 L NO 20072325L NO 20072325 A NO20072325 A NO 20072325A NO 20072325 A NO20072325 A NO 20072325A NO 20072325 L NO20072325 L NO 20072325L
Authority
NO
Norway
Prior art keywords
hydrochlorothiazide
telmisartan
combination therapy
therapy including
approx
Prior art date
Application number
NO20072325A
Other languages
English (en)
Norwegian (no)
Inventor
Axel Riedel
Helmut E Schumacher
Peter Boehm
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35589356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20072325(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20072325L publication Critical patent/NO20072325L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
NO20072325A 2004-12-17 2007-05-04 Kombinasjonsterapi omfattende telmisartan og hydroklortiazid NO20072325L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63706204P 2004-12-17 2004-12-17
PCT/EP2005/013224 WO2006063737A1 (en) 2004-12-17 2005-12-09 Combination therapy comprising telmisartan and hydrochlorothiazide

Publications (1)

Publication Number Publication Date
NO20072325L true NO20072325L (no) 2007-07-06

Family

ID=35589356

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072325A NO20072325L (no) 2004-12-17 2007-05-04 Kombinasjonsterapi omfattende telmisartan og hydroklortiazid

Country Status (15)

Country Link
EP (1) EP1827424A1 (enrdf_load_stackoverflow)
JP (1) JP2008524136A (enrdf_load_stackoverflow)
KR (1) KR20070097511A (enrdf_load_stackoverflow)
CN (1) CN101080225A (enrdf_load_stackoverflow)
AR (1) AR052052A1 (enrdf_load_stackoverflow)
AU (1) AU2005315855A1 (enrdf_load_stackoverflow)
BR (1) BRPI0519656A2 (enrdf_load_stackoverflow)
CA (1) CA2589493A1 (enrdf_load_stackoverflow)
EA (1) EA200701159A1 (enrdf_load_stackoverflow)
IL (1) IL183944A0 (enrdf_load_stackoverflow)
NO (1) NO20072325L (enrdf_load_stackoverflow)
PE (1) PE20060768A1 (enrdf_load_stackoverflow)
TW (1) TW200637546A (enrdf_load_stackoverflow)
UY (1) UY29274A1 (enrdf_load_stackoverflow)
WO (1) WO2006063737A1 (enrdf_load_stackoverflow)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232828B2 (en) 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1970053A1 (en) * 2007-03-14 2008-09-17 Boehringer Ingelheim Pharma GmbH & Co. KG Pharmaceutical composition
JP4879351B2 (ja) * 2007-10-19 2012-02-22 大塚製薬株式会社 医薬固形製剤
WO2009058950A2 (en) 2007-10-30 2009-05-07 Dr. Reddy's Laboratories Ltd. Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
US20110008428A1 (en) 2008-03-19 2011-01-13 Ratiopharm Gmbh Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic
EP2310385B1 (en) 2008-07-31 2017-06-07 Takeda Pharmaceutical Company Limited Solid pharmaceutical composition
GB0822170D0 (en) * 2008-12-04 2009-01-14 Arrow Int Ltd Telmisartan with diuretic formulations
EP2443094B1 (en) 2009-06-19 2013-03-20 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of telmisartan
WO2011002425A2 (en) * 2009-07-02 2011-01-06 Bilgig Mahmut Pharmaceutical composition increasing solubility and stability
WO2011002423A2 (en) * 2009-07-02 2011-01-06 Mahmut Bilgic Solubility enhancing pharmaceutical composition
TR200906506A2 (tr) 2009-08-24 2011-03-21 Bi̇lgi̇ç Mahmut Telmisartan içeren katı dozaj formları.
WO2011161123A2 (en) 2010-06-21 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Multilayer pharmaceutical tablet comprising telmisartan and a diuretic
WO2014119767A1 (ja) * 2013-01-31 2014-08-07 沢井製薬株式会社 テルミサルタンとヒドロクロロチアジドとを含有する多層錠剤
ES2847904T3 (es) * 2013-07-23 2021-08-04 Daiichi Sankyo Co Ltd Medicamento para la prevención o el tratamiento de la hipertensión
CN106562973A (zh) * 2016-11-06 2017-04-19 成都先先先生物科技有限公司 一种抗高血压药物复方制剂
CN107501192A (zh) * 2017-08-15 2017-12-22 中国科学院上海药物研究所 替米沙坦与氢氯噻嗪的共晶
CN108653227A (zh) * 2018-08-09 2018-10-16 湖北舒邦药业有限公司 一种替米沙坦氢氯噻嗪片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229085C2 (de) * 1992-09-01 1996-07-11 Boehringer Mannheim Gmbh Längliche, teilbare Tablette
AU2002242676B2 (en) * 2002-01-16 2008-05-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof

Also Published As

Publication number Publication date
IL183944A0 (en) 2007-10-31
TW200637546A (en) 2006-11-01
AR052052A1 (es) 2007-02-28
KR20070097511A (ko) 2007-10-04
BRPI0519656A2 (pt) 2009-03-03
EA200701159A1 (ru) 2007-12-28
AU2005315855A1 (en) 2006-06-22
JP2008524136A (ja) 2008-07-10
PE20060768A1 (es) 2006-09-29
WO2006063737A1 (en) 2006-06-22
UY29274A1 (es) 2006-07-31
CA2589493A1 (en) 2006-06-22
EP1827424A1 (en) 2007-09-05
CN101080225A (zh) 2007-11-28

Similar Documents

Publication Publication Date Title
NO20072325L (no) Kombinasjonsterapi omfattende telmisartan og hydroklortiazid
AU2003210300A1 (en) The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure
JP6337170B2 (ja) ネコの全身性疾患の予防又は治療の為のアンジオテンシンｉｉ受容体アンタゴニスト
EP2248519A3 (en) Non-mucoadhesive film dosage forms
CL2008003595A1 (es) Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central.
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
NO20072931L (no) Forbedret doseringsregime av temozolomid for behandling av kreft basert pa pasientens MGMT-niva
WO2004017896A3 (en) Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin ii type i receptor antagonist
AR034517A1 (es) Formulacion farmaceutica
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
WO2007098387A3 (en) Antihypertensive therapy
RU2010107843A (ru) Бупропиона гидробромид и его терапевтические применения
JP7109092B2 (ja) リドカインおよびジクロフェナクを含む神経障害性疼痛の治療用の医薬用貼付剤
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
WO2004096118A3 (en) Composition for improving cognition and memory
JP7109093B2 (ja) リドカインおよびジクロフェナクを含む医薬用貼付剤についての投与計画
AR075866A1 (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica.
SE9902597D0 (sv) New use
IS8373A (is) Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn
ECSP11010999A (es) Combinación de dosis fija en la forma de una tableta de dos capas o de una sola capa de alisquireno y amlodipina
EA200901145A1 (ru) Применение рибофлавина в лечении гипертензии
WO2006124544A3 (en) Use of tyrosine kinase inhibitors in the treatment of metabolic disorders
TH83710A (th) การบำบัดรวม
WO2009134056A3 (ko) 약제학적 제제

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application